
Gigi Georgiana Huang
Examiner (ID: 703, Phone: (571)272-9073 , Office: P/1621 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1609, 1612, 1629, 1621, 1617, 1613, 1627 |
| Total Applications | 773 |
| Issued Applications | 215 |
| Pending Applications | 86 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7436752
[patent_doc_number] => 20040185111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Method of preparing biologically active formulations'
[patent_app_type] => new
[patent_app_number] => 10/728196
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12021
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10728196
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/728196 | Method of preparing biologically active formulations | Dec 3, 2003 | Issued |
Array
(
[id] => 5865121
[patent_doc_number] => 20060099251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Formulations of finasteride'
[patent_app_type] => utility
[patent_app_number] => 10/535826
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1477
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535826
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535826 | Formulations of finasteride | Nov 20, 2003 | Abandoned |
Array
(
[id] => 5711022
[patent_doc_number] => 20060052367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Remedy for glaucoma comprising rho kinase inhibitor and beta-blocker'
[patent_app_type] => utility
[patent_app_number] => 10/535000
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2780
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052367.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535000 | Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker | Nov 16, 2003 | Issued |
Array
(
[id] => 7436743
[patent_doc_number] => 20040185110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Formulations of low solubility bioactive agents and processes for making the same'
[patent_app_type] => new
[patent_app_number] => 10/701229
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6744
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10701229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/701229 | Formulations of low solubility bioactive agents and processes for making the same | Nov 3, 2003 | Abandoned |
Array
(
[id] => 6917708
[patent_doc_number] => 20050095269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Gel plug for blockage of the canaliculus'
[patent_app_type] => utility
[patent_app_number] => 10/700699
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4654
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10700699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/700699 | Gel plug for blockage of the canaliculus | Nov 3, 2003 | Abandoned |
Array
(
[id] => 5820061
[patent_doc_number] => 20060024374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Pharmaceutical compositions suitable for the treatment of ophthalmic diseases'
[patent_app_type] => utility
[patent_app_number] => 10/533512
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2353
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024374.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533512
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533512 | Pharmaceutical compositions suitable for the treatment of ophthalmic diseases | Oct 30, 2003 | Abandoned |
Array
(
[id] => 4983486
[patent_doc_number] => 20070088045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Histone deacetylase inhibitors for treating degenerative diseases of the eye'
[patent_app_type] => utility
[patent_app_number] => 10/531747
[patent_app_country] => US
[patent_app_date] => 2003-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2550
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531747 | Histone deacetylase inhibitors for treating degenerative diseases of the eye | Oct 26, 2003 | Abandoned |
Array
(
[id] => 5733512
[patent_doc_number] => 20060258629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Photodynamic therapy for ocular neovascularization'
[patent_app_type] => utility
[patent_app_number] => 10/531546
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8550
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531546 | Photodynamic therapy for ocular neovascularization | Oct 19, 2003 | Abandoned |
Array
(
[id] => 5786789
[patent_doc_number] => 20060205771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Caspase inhibitors as anticancer agents'
[patent_app_type] => utility
[patent_app_number] => 10/529314
[patent_app_country] => US
[patent_app_date] => 2003-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11528
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529314 | Caspase inhibitors as anticancer agents | Sep 24, 2003 | Abandoned |
Array
(
[id] => 5705826
[patent_doc_number] => 20060194874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma'
[patent_app_type] => utility
[patent_app_number] => 10/537057
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3128
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537057 | Use of propionyl l-carnitine for the preparation of a medicament for the treatment of glaucoma | Sep 22, 2003 | Abandoned |
Array
(
[id] => 5865120
[patent_doc_number] => 20060099250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets'
[patent_app_type] => utility
[patent_app_number] => 10/525712
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4021
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099250.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525712
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525712 | Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets | Aug 19, 2003 | Abandoned |
Array
(
[id] => 5727584
[patent_doc_number] => 20060058345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Use of papaverine-like vasodilator and pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 10/523864
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4499
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523864 | Use of papaverine-like vasodilator and pharmaceutical composition | Aug 7, 2003 | Abandoned |
Array
(
[id] => 5732342
[patent_doc_number] => 20060257459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Carrier'
[patent_app_type] => utility
[patent_app_number] => 10/524090
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8092
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524090 | Carrier | Aug 6, 2003 | Issued |
Array
(
[id] => 5074875
[patent_doc_number] => 20070014850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Process for the preparation of dispersible tablets of cephalexin'
[patent_app_type] => utility
[patent_app_number] => 10/523116
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2769
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523116 | Process for the preparation of dispersible tablets of cephalexin | Jul 31, 2003 | Abandoned |
Array
(
[id] => 6931751
[patent_doc_number] => 20050282786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations'
[patent_app_type] => utility
[patent_app_number] => 10/519534
[patent_app_country] => US
[patent_app_date] => 2003-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3440
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282786.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519534
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519534 | Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations | Jul 10, 2003 | Abandoned |
Array
(
[id] => 202790
[patent_doc_number] => 07632853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Soluble, stable and concentrated pharmaceutical composition compromising ritonavir and process for preparing thereof'
[patent_app_type] => utility
[patent_app_number] => 10/517453
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8821
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 328
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517453
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517453 | Soluble, stable and concentrated pharmaceutical composition compromising ritonavir and process for preparing thereof | Jun 11, 2003 | Issued |
Array
(
[id] => 7110672
[patent_doc_number] => 20050208127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Rapidly disintegrating tablet and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 10/516274
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6566
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516274 | Rapidly disintegrating tablet and process for producing the same | Jun 5, 2003 | Abandoned |
Array
(
[id] => 5815037
[patent_doc_number] => 20060084685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Ophthalmological use of roflumilast for the treatment of diseases of the eye'
[patent_app_type] => utility
[patent_app_number] => 10/515896
[patent_app_country] => US
[patent_app_date] => 2003-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6688
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515896 | Ophthalmological use of roflumilast for the treatment of diseases of the eye | May 26, 2003 | Abandoned |
Array
(
[id] => 903432
[patent_doc_number] => 07335663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins'
[patent_app_type] => utility
[patent_app_number] => 10/494788
[patent_app_country] => US
[patent_app_date] => 2003-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16723
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494788
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494788 | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins | May 26, 2003 | Issued |
Array
(
[id] => 7200310
[patent_doc_number] => 20050164993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Methods of treating allergic reactions'
[patent_app_type] => utility
[patent_app_number] => 10/514376
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13536
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514376
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514376 | Methods of treating allergic reactions | May 19, 2003 | Abandoned |